Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:
in the sixth column, expiration of approval, of row 40, Deltamethrin, the date is replaced by ‘31 October 2019’;
in the sixth column, expiration of approval, of row 48, Beta-cyfluthrin, the date is replaced by ‘31 October 2019’;
in the sixth column, expiration of approval, of row 64, Flurtamone, the date is replaced by ‘31 October 2019’;
in the sixth column, expiration of approval, of row 65, Flufenacet, the date is replaced by ‘31 October 2019’;
in the sixth column, expiration of approval, of row 67, Dimethenamid-p, the date is replaced by ‘31 October 2019’;
in the sixth column, expiration of approval, of row 69, Fosthiazate, the date is replaced by ‘31 October 2019’;
in the sixth column, expiration of approval, of row 101, Chlorothalonil, the date is replaced by ‘31 October 2019’;
in the sixth column, expiration of approval, of row 102, Chlorotoluron, the date is replaced by ‘31 October 2019’;
in the sixth column, expiration of approval, of row 103, Cypermethrin, the date is replaced by ‘31 October 2019’;
in the sixth column, expiration of approval, of row 104, Daminozide, the date is replaced by ‘31 October 2019’;
in the sixth column, expiration of approval, of row 105, Thiophanate-methyl, the date is replaced by ‘31 October 2019’;
in the sixth column, expiration of approval, of row 106, Tribenuron, the date is replaced by ‘31 October 2019’;
in the sixth column, expiration of approval, of row 107, MCPA, the date is replaced by ‘31 October 2019’;
in the sixth column, expiration of approval, of row 108, MCPB, the date is replaced by ‘31 October 2019’;
in the sixth column, expiration of approval, of row 117, 1-methylcyclopropene, the date is replaced by ‘31 October 2019’;
in the sixth column, expiration of approval, of row 119, Indoxacarb, the date is replaced by ‘31 October 2019’;
in the sixth column, expiration of approval, of row 160, Prosulfocarb, the date is replaced by ‘31 October 2019’;
in the sixth column, expiration of approval, of row 161, Fludioxonil, the date is replaced by ‘31 October 2019’;
in the sixth column, expiration of approval, of row 162, Clomazone, the date is replaced by ‘31 October 2019’;
in the sixth column, expiration of approval, of row 192, Diuron, the date is replaced by ‘30 September 2019’.